GlobeImmune Garners $15,000,000 New Financing

  • Feed Type
  • Date
    7/2/2014
  • Company Name
    GlobeImmune
  • Mailing Address
    1450 Infinite Drive Louisville, CO 80027 USA
  • Company Description
    GlobeImmune, Inc. (NASDAQ: GBIM), is a biopharmaceutical company pioneering the discovery, development and manufacturing of potent, targeted molecular immunotherapy products called Tarmogens for the treatment of cancer and infectious diseases.
  • Website
    http://www.globeimmune.com
  • Transaction Type
    IPO
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy